JP2021512680A - 真皮再生シート用バイオインク組成物、これを用いたオーダーメード型真皮再生シートの製造方法、および該製造方法を用いて製造されたオーダーメード型真皮再生シート - Google Patents
真皮再生シート用バイオインク組成物、これを用いたオーダーメード型真皮再生シートの製造方法、および該製造方法を用いて製造されたオーダーメード型真皮再生シート Download PDFInfo
- Publication number
- JP2021512680A JP2021512680A JP2020541724A JP2020541724A JP2021512680A JP 2021512680 A JP2021512680 A JP 2021512680A JP 2020541724 A JP2020541724 A JP 2020541724A JP 2020541724 A JP2020541724 A JP 2020541724A JP 2021512680 A JP2021512680 A JP 2021512680A
- Authority
- JP
- Japan
- Prior art keywords
- regeneration sheet
- dermis
- custom
- dermis regeneration
- adipose tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3633—Extracellular matrix [ECM]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/225—Fibrin; Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/60—Materials for use in artificial skin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y70/00—Materials specially adapted for additive manufacturing
- B33Y70/10—Composites of different types of material, e.g. mixtures of ceramics and polymers or mixtures of metals and biomaterials
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y80/00—Products made by additive manufacturing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B41—PRINTING; LINING MACHINES; TYPEWRITERS; STAMPS
- B41M—PRINTING, DUPLICATING, MARKING, OR COPYING PROCESSES; COLOUR PRINTING
- B41M5/00—Duplicating or marking methods; Sheet materials for use therein
- B41M5/0041—Digital printing on surfaces other than ordinary paper
- B41M5/0047—Digital printing on surfaces other than ordinary paper by ink-jet printing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
- C12N5/0698—Skin equivalents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/73—Hydrolases (EC 3.)
- C12N2501/734—Proteases (EC 3.4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
Abstract
【選択図】図1
Description
脂肪組織由来間質血管分画(SVF)細胞は、下記の段階を通じて収得した。
無菌手術室で医師の主導の下に脂肪吸引術を実施して脂肪組織を抽出した後、これを生理食塩水に混合した。そして、12,000rpm〜20,000rpm条件のホモジナイザー(homogenizer)を用いて機械的に脂肪組織からECMを分離した後、これを遠心分離した。遠心分離後の沈殿物をさらに遠心分離する過程を3回〜5回繰り返した後、最終的にECMを収得した。
図1は、本発明によるオーダーメード型真皮再生シートを製造するために、第1液および第2液をそれぞれ準備する過程を示すものである。具体的に、前記収得されたSVFとECMを混合注射器(mix syringe)を用いて混合した後、これに4.5mg/mlのフィブリノーゲンが混合されたアプロチニン液1mlと混合注射器(mix syringe)を用いて混合して、第1液を製造した。この際、第1液内のECMの含量を図2のように10wt%または20wt%に調節した。
本発明による真皮再生シートの効能を検証するために、4ヶ月齢の豚の皮膚を2.5cm×2.5cmのサイズに除去した後、前述した方法のように、豚の脂肪組織からSVFおよびECMを収得した。図3は、実験例2のための動物実験での皮膚を除去した写真を示すものである。
Claims (14)
- 脂肪組織由来間質血管分画、細胞外基質、およびフィブリノーゲンを含む第1液と、
トロンビンを含む第2液と、を含む、真皮再生シート用バイオインク組成物。 - 前記第1液での脂肪組織由来間質血管分画の濃度は、105個/ml〜107個/mlであることを特徴とする、請求項1に記載の真皮再生シート用バイオインク組成物。
- 前記第1液での細胞外基質の含量は、20wt%〜60wt%であることを特徴とする、請求項1に記載の真皮再生シート用バイオインク組成物。
- 前記細胞外基質は、5μm〜100μmの直径の粒子であることを特徴とする、請求項1に記載の真皮再生シート用バイオインク組成物。
- 前記第1液でのフィブリノーゲンの濃度は、4mg/ml〜50mg/mlであることを特徴とする、請求項1に記載の真皮再生シート用バイオインク組成物。
- 前記第2液でのトロンビンの濃度は、30IU/ml〜250IU/mlであることを特徴とする、請求項1に記載の真皮再生シート用バイオインク組成物。
- 前記脂肪組織由来間質血管分画および前記細胞外基質は、それぞれ、自己由来脂肪組織から抽出したものであることを特徴とする、請求項1に記載の真皮再生シート用バイオインク組成物。
- 前記第1液は、アプロチニンをさらに含むことを特徴とする、請求項1に記載の真皮再生シート用バイオインク組成物。
- (a)3Dスキャナを用いて、欠損された真皮部位の3次元データを収得する段階と、
(b)脂肪組織由来間質血管分画、細胞外基質、およびフィブリノーゲンを含む第1液を用いて、前記収得された3次元データの形状に対応する第1層を形成する段階と、
(c)トロンビンを含む第2液を前記第1層上に塗布して第2層を形成する段階と、
(d)前記第1層および前記第2層が反応して、真皮再生シートを形成する段階と、を含む、オーダーメード型真皮再生シートの製造方法。 - (a1)3Dプリンタを用いて収得された3次元データの形状に対応するモールドを製造する段階をさらに含み、段階(b)は、前記モールド内に前記第1液を塗布することを特徴とする、請求項9に記載のオーダーメード型真皮再生シートの製造方法。
- 段階(b)および段階(c)は、2回以上交互に反復して行われることを特徴とする、請求項9に記載のオーダーメード型真皮再生シートの製造方法。
- 段階(d)は、10分以内に完了することを特徴とする、請求項9に記載のオーダーメード型真皮再生シートの製造方法。
- 段階(b)および 段階(c)は、インクジェットプリンティングまたは3Dプリンティングを用いて行われることを特徴とする、請求項1に記載のオーダーメード型真皮再生シートの製造方法。
- 請求項9に記載の製造方法を用いて製造された、オーダーメード型真皮再生シート。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2018-0012220 | 2018-01-31 | ||
KR20180012220 | 2018-01-31 | ||
PCT/KR2018/012430 WO2019151611A1 (ko) | 2018-01-31 | 2018-10-19 | 진피 재생 시트용 바이오 잉크 조성물, 이를 이용한 맞춤형 진피 재생 시트의 제조방법, 및 상기 제조방법을 이용하여 제조된 맞춤형 진피 재생 시트 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2021512680A true JP2021512680A (ja) | 2021-05-20 |
JP7105898B2 JP7105898B2 (ja) | 2022-07-25 |
Family
ID=67478471
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020541724A Active JP7105898B2 (ja) | 2018-01-31 | 2018-10-19 | 真皮再生シート用バイオインク組成物、これを用いたオーダーメード型真皮再生シートの製造方法、および該製造方法を用いて製造されたオーダーメード型真皮再生シート |
Country Status (15)
Country | Link |
---|---|
US (1) | US20210030926A1 (ja) |
EP (1) | EP3747478B1 (ja) |
JP (1) | JP7105898B2 (ja) |
KR (2) | KR102068175B1 (ja) |
CN (1) | CN111670056B (ja) |
AU (1) | AU2018405440A1 (ja) |
BR (1) | BR112020015616B1 (ja) |
CL (1) | CL2020002005A1 (ja) |
CO (1) | CO2020009504A2 (ja) |
EC (1) | ECSP20045827A (ja) |
JO (1) | JOP20200188A1 (ja) |
MX (1) | MX2020008034A (ja) |
PE (1) | PE20211587A1 (ja) |
SG (1) | SG11202007127QA (ja) |
WO (1) | WO2019151611A1 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102586028B1 (ko) | 2019-10-08 | 2023-10-10 | 주식회사 로킷헬스케어 | 당뇨병성 족부병증 환자 맞춤형 피부 재생 시트의 제조방법 및 이를 이용하여 제조된 당뇨병성 족부병증 환자 맞춤형 피부 재생 시트 |
KR102091151B1 (ko) | 2019-10-08 | 2020-03-20 | 주식회사 로킷헬스케어 | 당뇨병성 족부병증 환자 맞춤형 피부 재생 시트의 제조방법 및 이를 이용하여 제조된 당뇨병성 족부병증 환자 맞춤형 피부 재생 시트 |
BR112022024233A2 (pt) * | 2020-05-29 | 2022-12-27 | Rokit Healthcare Inc | Composição de tratamento renal usando omento, kit médico de tratamento renal que compreende a mesma e filme de tratamento renal que compreende produto curado da mesma |
DE102020004900A1 (de) * | 2020-08-12 | 2022-02-17 | Universitätsmedizin Der Johannes Gutenberg-Universität Mainz | Autologe prävaskulisierte 3D-Druckverfahren-erzeugte Brustgewebe-Konstrukte und Verfahren zu deren Herstellung |
CN115103696A (zh) * | 2020-12-24 | 2022-09-23 | 罗基医疗保健公司 | 用于构建组织再生贴片的方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009502364A (ja) * | 2005-07-28 | 2009-01-29 | カーネギー メロン ユニバーシティ | 生体適合性ポリマーおよび使用方法 |
JP2015523142A (ja) * | 2012-06-19 | 2015-08-13 | オルガノボ,インク. | 操作した三次元の結合組織構成物およびそれを製造する方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003224710A1 (en) * | 2002-03-18 | 2003-10-08 | Carnegie Mellon University | Method and apparatus for preparing biomimetic scaffold |
CN101002964A (zh) * | 2006-12-07 | 2007-07-25 | 北京赛尔泰和生物医药科技有限公司 | 一种组织工程复合皮肤材料及其制备方法 |
ITMI20100601A1 (it) * | 2010-04-09 | 2011-10-10 | Luisa Benassi | "nuovo sostituto dermico e sua applicazione terapeutica" |
WO2013040087A2 (en) * | 2011-09-12 | 2013-03-21 | Organovo, Inc. | Platform for engineered implantable tissues and organs and methods of making the same |
CA2910017C (en) * | 2013-04-22 | 2022-07-05 | Sealantium Medical Ltd | Fibrinogen-based tissue adhesive patches |
CN103272288B (zh) * | 2013-06-24 | 2014-07-09 | 谢杨 | 基于生物打印技术的细胞-生物支架复合物的制备方法 |
US11529436B2 (en) * | 2014-11-05 | 2022-12-20 | Organovo, Inc. | Engineered three-dimensional skin tissues, arrays thereof, and methods of making the same |
KR102311639B1 (ko) * | 2015-03-26 | 2021-10-12 | 주식회사 티앤알바이오팹 | 심근조직 재생용 3차원 구조체의 제조방법 |
US20180280578A1 (en) * | 2015-07-21 | 2018-10-04 | Bioink Solutions Inc. | Bio-ink composition having improved physical and biological properties |
US20170165194A1 (en) * | 2015-12-14 | 2017-06-15 | Jiansheng MENG | Cosmetic and facial regeneration composition derived from potentiated adipose derived cells and supernatants thereof |
CN106178134B (zh) * | 2016-07-14 | 2019-07-19 | 鲁峰 | 一种含高度浓缩的脂肪来源干细胞和细胞外基质的脂肪移植材料及其纯物理制备方法和应用 |
JP6732582B2 (ja) | 2016-07-26 | 2020-07-29 | サーモス株式会社 | 金属製容器の洗浄装置及び洗浄方法 |
KR101710615B1 (ko) | 2016-09-07 | 2017-02-27 | 주식회사 파마리서치프로덕트 | 생착률을 증가시킨 이식용 진피층 및 이의 제조 방법 |
CN107050516A (zh) * | 2017-04-21 | 2017-08-18 | 王大鹏 | 一种富含脂肪干细胞和细胞外基质的脂肪凝胶制备方法 |
-
2018
- 2018-10-19 AU AU2018405440A patent/AU2018405440A1/en active Pending
- 2018-10-19 JO JOP/2020/0188A patent/JOP20200188A1/ar unknown
- 2018-10-19 JP JP2020541724A patent/JP7105898B2/ja active Active
- 2018-10-19 CN CN201880088353.8A patent/CN111670056B/zh active Active
- 2018-10-19 KR KR1020180125354A patent/KR102068175B1/ko active IP Right Grant
- 2018-10-19 PE PE2020001135A patent/PE20211587A1/es unknown
- 2018-10-19 WO PCT/KR2018/012430 patent/WO2019151611A1/ko active Application Filing
- 2018-10-19 EP EP18903984.5A patent/EP3747478B1/en active Active
- 2018-10-19 MX MX2020008034A patent/MX2020008034A/es unknown
- 2018-10-19 US US16/966,182 patent/US20210030926A1/en active Pending
- 2018-10-19 BR BR112020015616-7A patent/BR112020015616B1/pt active IP Right Grant
- 2018-10-19 SG SG11202007127QA patent/SG11202007127QA/en unknown
-
2019
- 2019-12-24 KR KR1020190174295A patent/KR20200001580A/ko not_active Application Discontinuation
-
2020
- 2020-07-30 CL CL2020002005A patent/CL2020002005A1/es unknown
- 2020-07-30 CO CONC2020/0009504A patent/CO2020009504A2/es unknown
- 2020-07-31 EC ECSENADI202045827A patent/ECSP20045827A/es unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009502364A (ja) * | 2005-07-28 | 2009-01-29 | カーネギー メロン ユニバーシティ | 生体適合性ポリマーおよび使用方法 |
JP2015523142A (ja) * | 2012-06-19 | 2015-08-13 | オルガノボ,インク. | 操作した三次元の結合組織構成物およびそれを製造する方法 |
Also Published As
Publication number | Publication date |
---|---|
KR102068175B1 (ko) | 2020-01-20 |
MX2020008034A (es) | 2020-09-17 |
RU2020124018A3 (ja) | 2022-02-28 |
EP3747478C0 (en) | 2023-07-12 |
CN111670056A (zh) | 2020-09-15 |
BR112020015616A2 (pt) | 2021-01-05 |
SG11202007127QA (en) | 2020-08-28 |
AU2018405440A1 (en) | 2020-08-27 |
EP3747478B1 (en) | 2023-07-12 |
EP3747478A1 (en) | 2020-12-09 |
CL2020002005A1 (es) | 2020-12-04 |
US20210030926A1 (en) | 2021-02-04 |
KR20190098907A (ko) | 2019-08-23 |
JOP20200188A1 (ar) | 2020-07-29 |
EP3747478A4 (en) | 2021-10-27 |
ECSP20045827A (es) | 2020-08-31 |
PE20211587A1 (es) | 2021-08-18 |
CN111670056B (zh) | 2023-01-10 |
CO2020009504A2 (es) | 2020-08-31 |
WO2019151611A1 (ko) | 2019-08-08 |
KR20200001580A (ko) | 2020-01-06 |
JP7105898B2 (ja) | 2022-07-25 |
BR112020015616B1 (pt) | 2023-11-21 |
RU2020124018A (ru) | 2022-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7105898B2 (ja) | 真皮再生シート用バイオインク組成物、これを用いたオーダーメード型真皮再生シートの製造方法、および該製造方法を用いて製造されたオーダーメード型真皮再生シート | |
You et al. | Cell therapy for wound healing | |
AU2018201536B2 (en) | Skin Substitutes And Methods For Hair Follicle Neogenesis | |
KR102136314B1 (ko) | 상처 치유 조성물의 제조를 위한 방법, 튜브 및 장치 | |
KR101102308B1 (ko) | 세포외기질 성분과 생체적합성 고분자를 포함하는 복합 필름 및 그 제조방법 | |
US7419661B2 (en) | Dermal sheath tissue in wound healing | |
US20160287855A1 (en) | Surgical methods/devices for tissue injury removal by tattooing of autologous stem cells | |
JP2022027930A (ja) | 幹細胞濾液製剤及びその調製方法 | |
EP0980270B1 (en) | Dermal sheath tissue in wound healing | |
RU2793240C9 (ru) | Композиция биочернил для листа для регенерации дермы, способ изготовления индивидуализированного листа для регенерации дермы с использованием композиции биочернил | |
RU2793240C2 (ru) | Композиция биочернил для листа для регенерации дермы, способ изготовления индивидуализированного листа для регенерации дермы с использованием композиции и индивидуализированный лист для регенерации дермы, изготовленный с использованием способа изготовления биочернил | |
JP5066699B2 (ja) | 粘膜組織由来の線維芽細胞、これを含有する組織改善材及びこれらの製造方法並びに利用方法 | |
JP7319382B2 (ja) | 凍結乾燥硝子軟骨パウダーを用いた軟骨再生用組成物の製造方法、これを用いて製造された軟骨再生用組成物、軟骨再生用組成物を用いた患者オーダーメード型軟骨再生用スキャフォールドの製造方法及び患者オーダーメード型軟骨再生用スキャフォールド | |
KR100539371B1 (ko) | 인체 세포의 체외배양 방법 | |
Svolacchia et al. | A protocol of a new regenerative treatment of chrono-aging and photo-aging with progenitors cells from adipose Micrograft obtained from MilliGraft® Kit | |
RU2526814C1 (ru) | Способ восстановления кожного покрова у пациентов с обширными ранами с дефектом мягких тканей (варианты) | |
Rostamzadeh et al. | Therapeutic mechanisms of fibroblast cells in the skin conditions; trends in clinical applications-A Review | |
Sinha et al. | Prefabrication and Prelamination |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200730 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200730 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210907 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20211206 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220128 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220614 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220712 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7105898 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |